(19)
(11) EP 1 165 142 A2

(12)

(88) Date of publication A3:
08.02.2001

(43) Date of publication:
02.01.2002 Bulletin 2002/01

(21) Application number: 00912299.5

(22) Date of filing: 23.03.2000
(51) International Patent Classification (IPC)7: A61K 47/48, A61K 9/127
(86) International application number:
PCT/CA0000/319
(87) International publication number:
WO 0057/919 (05.10.2000 Gazette 2000/40)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 25.03.1999 US 276057

(71) Applicants:
  • Sapientia Therapeutics Limited
    Montréal, Québec H3A 3M8 (CA)
  • Agene Research Institute
    Kamakura-shi, Kanagawa Pref 247-0063 (JP)

(72) Inventors:
  • SUGIMOTO, Masanobu
    Kanagawa 247-0074 (JP)
  • ARELLA, Max
    Laval,Québec H7X 3J6 (CA)
  • FURUICHI, Yasuhiro
    Kamakura-shi,Kanagawa-ken 247 (JP)

(74) Representative: Goulard, Sophie 
Cabinet Ores, 6, Avenue de Messine
75008 Paris Cedex
75008 Paris Cedex (FR)

   


(54) LIPID-BASED ARTIFICIAL PARTICLES INDUCING CELL-MEDIATED IMMUNITY